Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
M.D. Anderson Cancer Center |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00038025 |
The purpose of this study is to determine the side effects and antitumor response of patients with lymphoid malignancies to Deoxycoformycin (DCF)/Pentostatin.
Condition | Intervention | Phase |
---|---|---|
Peripheral T-Cell Lymphoma Cutaneous T-Cell Lymphoma Chronic Lymphocytic Leukemia |
Drug: Deoxycoformycin (DCF)/Pentostatin |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies |
Ages Eligible for Study: | 16 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Study ID Numbers: | DM94-026 |
Study First Received: | May 24, 2002 |
Last Updated: | March 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00038025 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Mycosis Fungoides Lymphoma Chronic lymphocytic leukemia Deoxycoformycin Pentostatin |
All other lymphomas Nucleoside analogue Adenosine deaminase inhibitor T-cells |
Pentostatin Peripheral T-cell Lymphoma Leukemia, Lymphoid Immunoproliferative Disorders Sezary Syndrome Mycosis Fungoides Lymphoma, T-Cell, Peripheral Mycoses Leukemia Lymphatic Diseases Chronic Lymphocytic Leukemia |
Cutaneous T-cell Lymphoma Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, T-Cell Leukemia, B-cell, Chronic Lymphoma, Non-Hodgkin Leukemia, B-Cell Lymphoproliferative Disorders Adenosine Lymphoma Lymphoma, T-Cell, Cutaneous |
Pentostatin Leukemia, Lymphoid Immunoproliferative Disorders Neoplasms by Histologic Type Molecular Mechanisms of Pharmacological Action Immune System Diseases Antineoplastic Agents Enzyme Inhibitors Sezary Syndrome Mycosis Fungoides Lymphoma, T-Cell, Peripheral Pharmacologic Actions |
Lymphatic Diseases Leukemia Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Therapeutic Uses Lymphoma, T-Cell Lymphoma, Non-Hodgkin Leukemia, B-Cell Lymphoproliferative Disorders Lymphoma Lymphoma, T-Cell, Cutaneous |